Defining timeliness in care for patients with lung cancer: a scoping review
- PMID: 35393318
- PMCID: PMC8990712
- DOI: 10.1136/bmjopen-2021-056895
Defining timeliness in care for patients with lung cancer: a scoping review
Abstract
Objectives: Early diagnosis and reducing the time taken to achieve each step of lung cancer care is essential. This scoping review aimed to examine time points and intervals used to measure timeliness and to critically assess how they are defined by existing studies of the care seeking pathway for lung cancer.
Methods: This scoping review was guided by the methodological framework for scoping reviews by Arksey and O'Malley. MEDLINE, EMBASE, CINAHL and PsycINFO electronic databases were searched for articles published between 1999 and 2019. After duplicate removal, all publications went through title and abstract screening followed by full text review and inclusion of articles in the review against the selection criteria. A narrative synthesis describes the time points, intervals and measurement guidelines used by the included articles.
Results: A total of 2113 articles were identified from the initial search. Finally, 68 articles were included for data charting process. Eight time points and 14 intervals were identified as the most common events researched by the articles. Eighteen different lung cancer care guidelines were used to benchmark intervals in the included articles; all were developed in Western countries. The British Thoracic Society guideline was the most frequently used guideline (20%). Western guidelines were used by the studies in Asian countries despite differences in the health system structure.
Conclusion: This review identified substantial variations in definitions of some of the intervals used to describe timeliness of care for lung cancer. The differences in healthcare delivery systems of Asian and Western countries, and between high-income countries and low-income-middle-income countries may suggest different sets of time points and intervals need to be developed.
Keywords: PREVENTIVE MEDICINE; PRIMARY CARE; PUBLIC HEALTH; RESPIRATORY MEDICINE (see Thoracic Medicine); Respiratory tract tumours.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Defining timeliness in care for patients with lung cancer: protocol for a scoping review.BMJ Open. 2020 Nov 4;10(11):e039660. doi: 10.1136/bmjopen-2020-039660. BMJ Open. 2020. PMID: 33148754 Free PMC article.
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Patient journey and timeliness of care for patients with breast cancer in Africa: a scoping review protocol.BMJ Open. 2024 Sep 5;14(9):e081256. doi: 10.1136/bmjopen-2023-081256. BMJ Open. 2024. PMID: 39242165 Free PMC article.
-
Health systems influence on the pathways of care for lung cancer in low- and middle-income countries: a scoping review.Global Health. 2020 Mar 18;16(1):23. doi: 10.1186/s12992-020-00553-8. Global Health. 2020. PMID: 32188467 Free PMC article.
-
Conducting Patient-Oriented Research in Low-Income and Middle-Income Countries: A Scoping Review.Patient. 2023 Jan;16(1):19-29. doi: 10.1007/s40271-022-00592-w. Epub 2022 Jul 22. Patient. 2023. PMID: 35869330
Cited by
-
Evaluating the Time Interval Between Symptoms Onset, Diagnosis, and Therapeutic Intervention in Lung Cancer: A Cross-Sectional Study in Southern Iran.Cancer Rep (Hoboken). 2024 Oct;7(10):e70026. doi: 10.1002/cnr2.70026. Cancer Rep (Hoboken). 2024. PMID: 39423347 Free PMC article.
References
-
- Wild CP, Weiderpass E, Stewart BW, eds. World Cancer Report: Cancer Research for Cancer Prevention. Lyon, France: International Agency for Research on Cancer, WHO, 2020.
-
- Allemani C, Matsuda T, Di Carlo V, et al. . Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018;391:1023–75. 10.1016/S0140-6736(17)33326-3 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical